Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
69,921,237
-
Share change
-
+675,431
-
Total reported value
-
$44,127,182,246
-
Put/Call ratio
-
159%
-
Price per share
-
$631.52
-
Number of holders
-
1,047
-
Value change
-
+$441,749,897
-
Number of buys
-
511
-
Number of sells
-
408
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2021
As of 31 Dec 2021 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,047 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 69,921,237 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, LOOMIS SAYLES & CO L P, GEODE CAPITAL MANAGEMENT, LLC, PUTNAM INVESTMENTS LLC, HARRIS ASSOCIATES L P, and NORTHERN TRUST CORP.
This table shows 1,058 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.